Sign in to view content

Factors Associated with Worsening Proliferative Diabetic Retinopathy

Carl W. Baker, MD, FASRS

Video
Published 2017

Related

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD
Michael N. Cohen, MD
Updates from the Field
2020
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019

Category: Diabetic Retinopathy

See more